Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...
The use of PICC lines in preterm infants increases the risk for systemic bacterial infections. The overall incidence of Catheter Related Bloodstream Infection (CRBSI) after PICC line removal is not ...
The origination of the central venous catheter technique is attributed to Werner Forrsmann in 1929, who won a Nobel Prize for Medicine in 1956 for his idea of delivering a drug directly into the heart ...
Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...
Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback